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Relato de Caso
Chylous ascites secondary to Hodgkin’s lymphoma in
a HIV/aids patient: case report and literature review
Ascite quilosa secundária a linfoma de Hodgkin em paciente com HIV/aids: relato de
caso e revisão da literatura
Mário Luciano de Mélo Silva Júnior1, Hildenice Ferreira Bernardes Leonídio1, Mariana Montenegro de Melo Lira2,
Luciana Cardoso Martins Arraes3, Carlos Eduardo Guimarães Padilha3, Paulo Sérgio Ramos de Araújo3,4
ABSTRACT
Study design: case report. Case report: Man, 42 years old, diagnosed with aids two years ago, had
developed enlarging in abdominal volume six months from admission. Computed tomography imaging
showed free liquid in peritoneal cavity and increased retroperitoneal and mesenteric lymph nodes,
besides splenomegaly. Ascitic fluid had milky appearance and high triglycerides levels. Hodgkin's lym-
phoma (mixed cellularity) was confirmed by histopathological analysis of a video-laparoscopic lymph
node biopsy, Ann Arbor IIIS staging. Chemotherapy and continuation of highly active antiretroviral
therapy resulted in weight gain and reduction of abdominal volume. Chylous ascites is a rare condition,
which has a vast differential diagnosis. Discussion: In our review, the majority (15/18, 83%) of chy-
lous ascites in HIV/aids-patients are due to infectious causes (mainly Mycobacterium avium complex
and tuberculosis infection), in highly immunocompromised patients (mean TCD4=87cell/mL). To the
best of our knowledge, this is the first case of chylous ascites secondary to Hodgkin’s lymphoma in a
patient with aids.
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RESUMO
Tipo de estudo: relato de caso. Relato de caso: Homem, 42 anos, diagnosticado com aids há dois
anos, desenvolveu aumento de volume abdominal há seis meses da admissão. Tomografia computado-
rizada mostrou líquido livre na cavidade peritoneal, além de linfonodos mesentéricos e esplenomegalia.
O líquido ascítico tinha aspecto leitoso e alto nível de triglicerídeos. Após amplo diagnóstico diferencial,
diagnosticamos linfoma de Hodgkin tipo celularidade mista por biópsia linfonodal via videolaparoscópica,
Ann Arbor IIIS. Quimioterapia e continuação da terapia antirretroviral de alta potência resultaram em
ganho de peso e redução do volume abdominal. Ascite quilosa é uma entidade rara, que possui vários
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Introduction
Hodgkin’s lymphoma (HL) is a non-defining
human immunodeficiency virus (HIV)-associated dis-
ease that seems to be increasing in occurrence
among HIV-infected people, while other lymphomas
became less frequent.1 Chylous ascites (CA) is a
condition known since 16th century, but it is an in-
frequent manifestation of malignancies, and it is
even uncommon as presentation of HL.2 In HIV/aids
population, the occurrence of CA seems to be mainly
due to infectious diseases (Table 1). In this report,
we present the first case of CA secondary to HL in a
HIV-infected patient.
Table 1: Review of case reports on chylous ascites in HIV-infected people
Author Age CD4 Etiology ART Outcomea
Shaik et al, 20143 44 103 MAC/IRIS Y Good
Shen et al, 20124 47 66 Penicillium marneffei N Good
Summachiwakij, 20125 39 - Tuberculous pericarditis Y Good
Rabie, 20106 3 4 Tuberculosis/IRIS Y Good
Philips, 20097 38 210 MAC/IRIS Y Good
40 150 MAC/IRIS Y Poor
43 150 MAC/IRIS/Septic thrombophlebitis Y Poor
42 60 MAC/IRIS Y Good
34 30 MAC/IRIS Y Good
23 110 MAC/IRIS Y Poor
Foschi et al, 20078 43 205 B-cell NHL Y Poor
Sathiravikarn et al, 20069 30 19 Tuberculosis N Good
Ekwcani, 200210 53 - Tuberculosis N Good
Keaveny et al, 199911 35 20 MAC N Good
Rollhauser et al, 199612 42 0 MAC Y Poor
Arsura et al, 199413 41 - Tuberculosis Y Good
Lin, 199414 43 - Kaposi N Poor
aMedian follow-up of 6 months for Good (=no recurrence, 12/18, 67%) and 7 months for Poor (=death or recurrence, 6/18, 33%). Age in
years old, all patients were men. ART=Antiretroviral therapy when diagnosis (Y=yes, 13/18, 72%; N=no/information no available, 5/18,
28%), NHL=non-Hodgkin’s lymphoma, MAC=Mycobacterium avium complex, IRIS=Immune reconstitution inflammatory syndrome, -=no
information available.
diagnósticos diferenciais. Discussão: Em nossa revisão, a maioria (15/18, 83%) dos casos de ascite
quilosa em paciente com HIV/aids deveu-se a causa infecciosa (especialmente pelo Mycobacterium
avium complex e tuberculose), em pacientes gravemente imunocomprometidos (linfócitos T-CD4
médio=84células/mm3). Até onde sabemos, este é o primeiro caso de ascite quilosa secundária a linfoma
de Hodgkin em paciente com aids.
Palavras-chave: Ascite Quilosa. AIDS. Doença de Hodgkin. Linfoma Relacionado a AIDS. Trombose
Venosa.
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Figure 2: Mesenteric lymph node biopsy. Strong CD30 positivity in
Hodgkin’s cellules.
Figure 1: Computed tomography with ionic contrast of thoraco-
abdominal region. White arrow points to left pleural effusion, white
arrow-head indicates to 3 cm retro-peritoneal lymph node, black
arrow-head shows ascitic fluid. Note splenomegaly.
Case report
Man, 42 years old, living with HIV, on irregu-
lar use of efavirenz + lamivudine + tenofovir as
highly active antiretroviral therapy (HAART) since
diagnosis, HIV viral load=3000 copies/mL, count
TCD4=318/mL, had developed enlarging in abdomi-
nal volume six months from admission in our
Infectology service, with no constitutional symp-
toms. HIV infection was diagnosed 2 years ago in a
neurotoxoplasmosis presentation. On physical ex-
amination, he presented lipodistrophy, oedema in
lower limbs (right bigger than left), temporal wast-
ing, globose abdomen (94cm in circumference),
shifting dullness to percussion, fluid waves. No signs
of liver disease or palpable lymph nodes.
Ultrasonography/computed tomography im-
aging showed free liquid in peritoneal cavity and
increased, but usual aspect retroperitoneal and
mesenteric lymph nodes, discrete splenomegaly
(Figure 1) and no special comments for liver includ-
ing venous system. Doppler venous ultrasonogra-
phy showed extensive thrombosis in right common
femoral vein. Study of this ascitic fluid revealed milky
appearance and high triglyceride levels (708mg/dL,
cell count = 1,170/mm3 [45% neutrophils, 25% lym-
phocytes). Polymerase chain reaction for Mycobac-
terium tuberculosis, Gram stain and cultures (pyo-
genic and fungal) were negative in ascites, as well
no neoplastic cells were found. Immunochromato-
graphic test for filariasis was also negative. Pancre-
atic, liver and esophagogastroduodenoscopy showed
no abnormalities. Lymphoscintigraphy resulted nor-
mal. Videolaparoscopic assessment revealed thick-
ened peritoneum, enlarged mesenteric lymph nodes
(biopsy was performed) and limited further evalua-
tion because of the opaque liquid.
During investigation, patient was in full anti-
coagulation and on hipolipidic and supplemented
with medium chain triglycerides diet. Although, he
had evolved with weight loss and new large deep
venous thrombosis (DVT) in the left leg. Addition-
ally, this patient has left pleural effusion, which we
had not punctured. Origin of this pleural effusion
(cardiac, chylous or both) was not defined.
Histopathologic data from mesenteric ganglia
were suggestive for classic mixed cellularity HL,
which was confirmed by imunohistochemistry
(CD45-, CD15+, CD30+) (Figure 2). Bone marrow
study was negative for lymphoma infiltration. HL
staging resulted in Ann Arbor IIIS.
Treatment with AVBD scheme (adriamycin,
vinblastine, bleomycin, dacarbazine) and mainte-
nance of HAART resulted in reduction of abdominal
volume and weight gain. At six months’ evaluation
patient had no complaints flaccid abdomen with
80cm of circumference, undetectable viral load and
count TCD4=213/mL.
We performed an integrative review of litera-
ture in Pubmed, LILACS and BIREME with “hiv OR
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aids AND chylous ascites OR chyloperitoneum”
terms; only articles which abstract was not acces-
sible were excluded. Results are discussed in text
and summarized in Table 1. Informed consent was
obtained from the patient prior to produce this
manuscript.
Discussion
CA is a rare condition (1:20,000 admissions
in general hospital, but 1:2,248 HIV hospital inter-
ments)7 first described in 1691, which has a vast
differential diagnosis,15 such as trauma, post ab-
dominal surgery, liver cirrhosis, cancer, infectious
(tuberculosis, Mycobacterium avium complex, filari-
asis, paracoccidioidomycosis),16 pancreatic, yellow-
nail syndrome, lymphatic malformation, among oth-
ers. Although lymphoma is frequently remembered
in differential diagnosis of CA (expected frequency
of 33-50% of all cases), recent review cites fre-
quency of 8% among adult cases,15 and in HIV popu-
lation this frequency seems to be even lower. We
reviewed the all 18 published cases of CA in HIV/
aids population, most of them (15/18, 83%) caused
by infectious diseases, markedly tuberculosis and
Mycobacterium avium complex, in highly immuno-
compromised patients (mean TCD4=87cell/mL,
mean age=38yr-old) (Table 1). Kaposi’s sarcoma14
and non-Hodgkin’s lymphoma8 were already re-
ported as causative diseases of CA, but to the best
of our knowledge this is the first case of CA associ-
ated with classic HL in a HIV/aids patient.
Mechanisms of CA genesis in these cases are
secondary to lymph node fibrosis, obstruction or
both caused by malignant infiltration that leads to
high pressure in pre-nodal lymphatic vessels and
exudation from subserosal lymphatics into perito-
neal cavity. CA is an infrequent condition and, be-
tween lymphomas, presentation with CA is more
common in non-HL due to more prominent mesen-
teric adenopathy.2 We believe that the higher inci-
dence of non-HL and its preference for abdominal
region justify this relation with CA, nevertheless HL
in HIV/aids is usually aggressive, presenting with
extra-nodal disease in 74-92%.17 Curiously, all re-
ported cases of CA in HIV were in men.
HL associated to HIV seems to be increasing
in frequency,1,18 due reduction of incidence of oth-
ers cancers caused by HAART. This entity has a dif-
ferent epidemiological profile in HIV people com-
pared with non-HIV ones19: a) the incidence peak
occurs ten years later; b) it has an incidence ten-
fold higher; c) the most common histological sub-
type is mixed cellularity (as this case) in contrast
with nodular sclerosis in non-HIV; and d) bone mar-
row infiltration is more frequent. Recent data sug-
gests no association between TCD4 or HIV counts
and risk for HL. HL treatment in HIV-infected people
has shown favourable outcomes compared whit pre-
HAART era. Currently, complete remission is
achieved in 87% of patients staged as III/IV in AVBD
+ HAART scheme.19
Recurrent DVT during full anticoagulation is
not frequent and suggest a highly thrombogenic
status. HIV itself promotes perturbation in coagu-
lation homeostasis (deficiency of proteins C and S,
heparin cofactor II and antithrombin, among oth-
ers), leading to a risk for DVT tenfold higher than
HIV-negative population.20 Also in CA patients, add-
ing to Virchow’s triad, is noted stasis caused by in-
crease in inferior cava vein pressure (in this review
we found a frequency of 19% of lower leg oedema
at presentation of CA).
Conclusion
CA is a challenging symptom owning its vast
differential diagnosis. We presented a case of CA
secondary to HL (mixed cellularity) in a HIV-infected
patient, which was never previously reported. Al-
though in HIV/aids population infectious causes are
the most common, HL should be remembered.
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